{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:44:03Z","timestamp":1775486643734,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJID Regions"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ijregi.2024.100453","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T06:38:05Z","timestamp":1726727885000},"page":"100453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["India should invest in the expansion of genomic epidemiology for vector-borne diseases filariasis, malaria and visceral leishmaniasis that are targeted for elimination"],"prefix":"10.1016","volume":"13","author":[{"given":"Nandini","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4654-5463","authenticated-orcid":false,"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijregi.2024.100453_bib0001","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1093\/aje\/kwz193","article-title":"The evolving field of genetic epidemiology: from familial aggregation to genomic sequencing","volume":"188","author":"Duggal","year":"2019","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijregi.2024.100453_bib0002","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13073-021-00886-y","article-title":"The impact of genomics on precision public health: beyond the pandemic","volume":"13","author":"Khoury","year":"2021","journal-title":"Genome Med"},{"key":"10.1016\/j.ijregi.2024.100453_bib0003","doi-asserted-by":"crossref","first-page":"963","DOI":"10.15212\/ZOONOSES-2022-0037","article-title":"One health approach for the control of zoonotic diseases","volume":"2","author":"Erkyihun","year":"2022","journal-title":"Zoonoses"},{"key":"10.1016\/j.ijregi.2024.100453_bib0004","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1017\/ash.2023.119","article-title":"On-demand, hospital-based, severe acute respiratory coronavirus virus 2 (SARS-CoV-2) genomic epidemiology to support nosocomial outbreak investigations: a prospective molecular epidemiology study","volume":"3","author":"Benoit","year":"2023","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"10.1016\/j.ijregi.2024.100453_bib0005","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s10038-007-0200-z","article-title":"SNPs in disease gene mapping, medicinal drug development and evolution","volume":"52","author":"Shastry","year":"2007","journal-title":"J Hum Genet"},{"key":"10.1016\/j.ijregi.2024.100453_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144792","article-title":"Overwhelming mutations or SNPs of SARS-CoV-2: A point of caution","volume":"752","author":"Vankadari","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.ijregi.2024.100453_bib0007","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/AAC.02220-13","article-title":"Inhibition of protein synthesis and malaria parasite development by drug targeting of methionyl-tRNA synthetases","volume":"59","author":"Hussain","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijregi.2024.100453_bib0008","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/s41564-022-01233-6","article-title":"The potential of genomics for infectious disease forecasting","volume":"7","author":"Stockdale","year":"2022","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ijregi.2024.100453_bib0009","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12915-016-0337-3","article-title":"Frequency of influenza H3N2 intra-subtype reassortment: attributes and implications of reassortant spread","volume":"14","author":"Maljkovic Berry","year":"2016","journal-title":"BMC Biol"},{"key":"10.1016\/j.ijregi.2024.100453_bib0010","doi-asserted-by":"crossref","first-page":"S405","DOI":"10.1093\/infdis\/jiab269","article-title":"Influenza vaccines: successes and continuing challenges","volume":"224","author":"Becker","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijregi.2024.100453_bib0011","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1126\/science.1198545","article-title":"Rapid pneumococcal evolution in response to clinical interventions","volume":"331","author":"Croucher","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ijregi.2024.100453_bib0012","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11908-024-00836-w","article-title":"Whole genome sequencing applications in hospital epidemiology and infection prevention","volume":"26","author":"Doll","year":"2024","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.ijregi.2024.100453_bib0013","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41576-022-00483-8","article-title":"Phylogenetic and phylodynamic approaches to understanding and combating the early SARS-CoV-2 pandemic","volume":"23","author":"Attwood","year":"2022","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ijregi.2024.100453_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146387","article-title":"Role of genomics in combating COVID-19 pandemic","volume":"823","author":"Saravanan","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.ijregi.2024.100453_bib0015","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s10096-020-03899-4","article-title":"The genetic sequence, origin, and diagnosis of SARS-CoV-2","volume":"39","author":"Wang","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijregi.2024.100453_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009885","article-title":"Current status of therapeutic monoclonal antibodies against SARS-CoV-2","volume":"17","author":"Kumar","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijregi.2024.100453_bib0017","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.chom.2021.02.003","article-title":"Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies","volume":"29","author":"Greaney","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijregi.2024.100453_bib0018","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.ijregi.2024.100453_bib0019","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/v14030640","article-title":"Mutations and evolution of the SARS-CoV-2 spike protein","volume":"14","author":"Magazine","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ijregi.2024.100453_bib0020","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41592-023-01769-3","article-title":"Outbreak.info. Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations","volume":"20","author":"Gangavarapu","year":"2023","journal-title":"Nat Methods"},{"key":"10.1016\/j.ijregi.2024.100453_bib0021","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40246-021-00326-3","article-title":"COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy","volume":"15","author":"Novelli","year":"2021","journal-title":"Hum Genomics"},{"key":"10.1016\/j.ijregi.2024.100453_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2023.105405","article-title":"Global SARS-CoV-2 genomic surveillance: what we have learned (so far)","volume":"108","author":"Tosta","year":"2023","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.ijregi.2024.100453_bib0023","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s12276-021-00603-0","article-title":"The evolution and future of influenza pandemic preparedness","volume":"53","author":"Harrington","year":"2021","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.ijregi.2024.100453_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010078","article-title":"Current state of Ebola virus vaccines: A snapshot","volume":"17","author":"Woolsey","year":"2021","journal-title":"PLOS Pathog"},{"key":"10.1016\/j.ijregi.2024.100453_bib0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/0974-777X.170495","article-title":"The Ebola outbreak of 2014\u20132015: from coordinated multilateral action to effective disease containment, vaccine development, and beyond","volume":"7","author":"Wojda","year":"2015","journal-title":"J Glob Infect Dis"},{"key":"10.1016\/j.ijregi.2024.100453_bib0026","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1473-3099(22)00764-2","article-title":"The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy Flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials","volume":"23","author":"Essink","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijregi.2024.100453_bib0027","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/vaccines8020266","article-title":"Current status of Zika virus vaccines: successes and challenges","volume":"8","author":"Pattnaik","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.ijregi.2024.100453_bib0028","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.pt.2017.09.003","article-title":"Mining filarial genomes for diagnostic and therapeutic targets","volume":"34","author":"Bennuru","year":"2018","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.ijregi.2024.100453_bib0029","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3389\/fgene.2019.01282","article-title":"Genomic epidemiology in filarial nematodes: transforming the basis for elimination program decisions","volume":"10","author":"Hedtke","year":"2020","journal-title":"Front Genet"},{"key":"10.1016\/j.ijregi.2024.100453_bib0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12936-019-2784-0","article-title":"Use cases for genetic epidemiology in malaria elimination","volume":"18","author":"Dalmat","year":"2019","journal-title":"Malar J"},{"key":"10.1016\/j.ijregi.2024.100453_bib0031","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijpara.2020.12.011","article-title":"Geographical spread and structural basis of sulfadoxine-pyrimethamine drug-resistant malaria parasites","volume":"51","author":"Chaturvedi","year":"2021","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.ijregi.2024.100453_bib0032","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12936-024-04904-3","article-title":"Widespread pfhrp2\/3 deletions and HRP2-based false-negative results in southern Ethiopia","volume":"23","author":"Mekonen","year":"2024","journal-title":"Malar J"},{"key":"10.1016\/j.ijregi.2024.100453_bib0033","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpddr.2019.10.001","article-title":"Profiles of Kelch mutations in Plasmodium falciparum across South Asia and their implications for tracking drug resistance","volume":"11","author":"Chhibber-Goel","year":"2019","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijregi.2024.100453_bib0034","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12936-022-04398-x","article-title":"Molecular surveillance of artemisinin resistance-related Pfk13 and pfcrt polymorphisms in imported Plasmodium falciparum isolates reported in eastern China from 2015 to 2019","volume":"21","author":"Kong","year":"2022","journal-title":"Malar J"},{"key":"10.1016\/j.ijregi.2024.100453_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2022.102193","article-title":"Plasmodium falciparum resistance to artemisinin-based combination therapies","volume":"69","author":"Ward","year":"2022","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.ijregi.2024.100453_bib0036","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3390\/pathogens12081061","article-title":"Malaria genomics, vaccine development, and microbiome","volume":"12","author":"Su","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.ijregi.2024.100453_bib0037","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41576-021-00349-5","article-title":"Advances and opportunities in malaria population genomics","volume":"22","author":"Neafsey","year":"2021","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.ijregi.2024.100453_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009652","article-title":"Genetic diversity in two leading Plasmodium vivax malaria vaccine candidates AMA1 and MSP119 at three sites in India","volume":"15","author":"Kale","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijregi.2024.100453_bib0039","doi-asserted-by":"crossref","first-page":"e11902","DOI":"10.1016\/j.heliyon.2022.e11902","article-title":"Insecticide resistance status of malaria vectors in the malaria endemic states of India: implications and way forward for malaria elimination","volume":"8","author":"Raghavendra","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.ijregi.2024.100453_bib0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/0972-9062.373616","article-title":"Dried blood spots: a robust tool for malaria surveillance in countries targeting elimination","volume":"60","author":"Nain","year":"2023","journal-title":"J Vector Borne Dis"},{"key":"10.1016\/j.ijregi.2024.100453_bib0041","doi-asserted-by":"crossref","first-page":"e12613","DOI":"10.7554\/eLife.12613","article-title":"Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent","volume":"5","author":"Imamura","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.ijregi.2024.100453_bib0042","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2334-13-153","article-title":"Evaluation of PCR procedures for detecting and quantifying Leishmania donovani DNA in large numbers of dried human blood samples from a visceral leishmaniasis focus in Northern Ethiopia","volume":"13","author":"Abbasi","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijregi.2024.100453_bib0043","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3347\/kjp.2022.60.6.379","article-title":"Leishmania vaccines: the current situation with its promising aspect for the future","volume":"60","author":"Dinc","year":"2022","journal-title":"Korean J Parasitol"},{"key":"10.1016\/j.ijregi.2024.100453_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009492","article-title":"India can consider integration of three eliminable disease control programmes on malaria, lymphatic filariasis, and visceral leishmaniasis","volume":"17","author":"Rahi","year":"2021","journal-title":"PLOS Pathog"},{"key":"10.1016\/j.ijregi.2024.100453_bib0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-004198","article-title":"For malaria elimination India needs a platform for data integration","volume":"5","author":"Rahi","year":"2020","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.ijregi.2024.100453_bib0046","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3390\/v14112532","article-title":"Challenges and opportunities for global genomic surveillance strategies in the COVID-19 era","volume":"14","author":"Ling-Hu","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ijregi.2024.100453_bib0047","article-title":"Malaria control initiatives that have the potential to be gamechangers in India's quest for malaria elimination","volume":"2","author":"Rahi","year":"2022","journal-title":"Lancet Reg Health Southeast Asia"}],"container-title":["IJID Regions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707624001243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707624001243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T11:54:37Z","timestamp":1738929277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772707624001243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":47,"alternative-id":["S2772707624001243"],"URL":"https:\/\/doi.org\/10.1016\/j.ijregi.2024.100453","relation":{},"ISSN":["2772-7076"],"issn-type":[{"value":"2772-7076","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"India should invest in the expansion of genomic epidemiology for vector-borne diseases filariasis, malaria and visceral leishmaniasis that are targeted for elimination","name":"articletitle","label":"Article Title"},{"value":"IJID Regions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijregi.2024.100453","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"100453"}}